MetaADEDB 2.0 @ LMMD
Zolpidem
(NYVVVBWEVRSKIU-UHFFFAOYSA-N)
Structure
SMILES
OC(C(C(=O)O)O)C(=O)O.Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
Molecular Formula:
C23H27N3O7
Molecular Weight:
457.476
Log P:
1.1262
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
152.67
CAS Number(s):
99294-93-6; 103188-50-7
Synonym(s)
1.
Zolpidem
2.
Ambien
3.
Amsic
4.
Bikalm
5.
Dalparan
6.
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate
7.
SL 80.0750
8.
SL-800750-23-N
9.
Stilnoct
10.
Stilnox
11.
Zodormdura
12.
Zoldem
13.
Zolirin
14.
Zolpi-Lich
15.
Zolpidem 1A Pharma
16.
Zolpidem AbZ
17.
Zolpidem Hemitartrate
18.
Zolpidem Tartrate
19.
Zolpimist
20.
Zolpinox
21.
SL 800750 23 N
22.
Zolpi Lich
External Link(s)
MeSHD000077334
PubChem Compound18004026
CHEMBLCHEMBL1723343
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 469US FAERS
2Product substitution issueFAERS: 109US FAERS
3SomnambulismFAERS: 108US FAERS
4AmnesiaFAERS: 88US FAERS
5Drug abuseFAERS: 77US FAERS
6SomnolenceFAERS: 55US FAERS
7Drug DependenceFAERS: 44US FAERS
8DeliriumFAERS: 40US FAERS
9HeadacheFAERS: 40US FAERS
10DizzinessFAERS: 38US FAERS
11Feeling abnormalFAERS: 38US FAERS
12AnxietyFAERS: 35US FAERS
13Completed SuicideFAERS: 34US FAERS
14OverdoseFAERS: 34US FAERS
15Toxicity to various agentsFAERS: 28US FAERS
16DisorientationFAERS: 27US FAERS
17FatigueFAERS: 27US FAERS
18NauseaFAERS: 27US FAERS
19Product quality issueFAERS: 26US FAERS
20SoporFAERS: 26US FAERS
21AgitationFAERS: 25US FAERS
22Intentional product misuseFAERS: 24US FAERS
23Sleep-related eating disorderFAERS: 24US FAERS
24VomitingFAERS: 24US FAERS
25Medication ErrorFAERS: 23US FAERS
26Memory impairmentFAERS: 22US FAERS
27Maternal exposure during pregnancyFAERS: 21US FAERS
28Abnormal sleep-related eventFAERS: 20US FAERS
29Drug withdrawal syndromeFAERS: 20US FAERS
30Middle insomniaFAERS: 20US FAERS
31Therapeutic response unexpected with drug substitutionFAERS: 20US FAERS
32Impaired driving abilityFAERS: 16US FAERS
33Suicide attemptFAERS: 16US FAERS
34TremorFAERS: 16US FAERS
35Incorrect dose administeredFAERS: 15US FAERS
36Depressed Level of ConsciousnessFAERS: 14US FAERS
37MalaiseFAERS: 14US FAERS
38PainFAERS: 14US FAERS
39Wrong technique in product usage processFAERS: 14US FAERS
40PalpitationsFAERS: 13US FAERS
41Pharmaceutical product complaintFAERS: 13US FAERS
42Altered state of consciousnessFAERS: 12US FAERS
43Intentional drug misuseFAERS: 12US FAERS
44Adverse eventFAERS: 11US FAERS
45AstheniaFAERS: 11US FAERS
46DysarthriaFAERS: 11US FAERS
47Initial insomniaFAERS: 11US FAERS
48TachycardiaFAERS: 11US FAERS
49Chest discomfortFAERS: 10US FAERS
50Drug ToleranceFAERS: 10US FAERS
51Therapeutic response unexpectedFAERS: 10US FAERS
52Wrong technique in drug usage processFAERS: 10US FAERS
53Intentional self-injuryFAERS: 9US FAERS
54Victim of sexual abuseFAERS: 9US FAERS
55AtaxiaFAERS: 8US FAERS
56Back PainFAERS: 8US FAERS
57DependenceFAERS: 8US FAERS
58Drug abuserFAERS: 8US FAERS
59LethargyFAERS: 8US FAERS
60Product taste abnormalFAERS: 8US FAERS
61RestlessnessFAERS: 8US FAERS
62AutomatismFAERS: 7US FAERS
63Chest PainFAERS: 7US FAERS
64DysgeusiaFAERS: 7US FAERS
65Hepatic EncephalopathyFAERS: 7US FAERS
66Product use issueFAERS: 7US FAERS
67PruritusFAERS: 7US FAERS
68SyncopeFAERS: 7US FAERS
69Accidental overdoseFAERS: 6US FAERS
70Cardiac ArrestFAERS: 6US FAERS
71Depressed moodFAERS: 6US FAERS
72DiplopiaFAERS: 6US FAERS
73Drug administration errorFAERS: 6US FAERS
74HypersensitivityFAERS: 6US FAERS
75Incorrect drug administration durationFAERS: 6US FAERS
76LacerationFAERS: 6US FAERS
77MeningomyeloceleFAERS: 6US FAERS
78ParasomniaFAERS: 6US FAERS
79Poor quality sleepFAERS: 6US FAERS
80Sleep TalkingFAERS: 6US FAERS
81UrticariaFAERS: 6US FAERS
82Abdominal discomfortFAERS: 5US FAERS
83Accidental exposureFAERS: 5US FAERS
84BlindnessFAERS: 5US FAERS
85BradycardiaFAERS: 5US FAERS
86BradyphreniaFAERS: 5US FAERS
87Congenital HydrocephalusFAERS: 5US FAERS
88DementiaFAERS: 5US FAERS
89Drug withdrawal convulsionsFAERS: 5US FAERS
90ErythemaFAERS: 5US FAERS
91HypersomniaFAERS: 5US FAERS
92HypotensionFAERS: 5US FAERS
93Impaired work abilityFAERS: 5US FAERS
94Intentional product use issueFAERS: 5US FAERS
95MyalgiaFAERS: 5US FAERS
96Physical assaultFAERS: 5US FAERS
97Psychomotor skills impairedFAERS: 5US FAERS
98Respiratory DepressionFAERS: 5US FAERS
99Restless Legs SyndromeFAERS: 5US FAERS
100RhabdomyolysisFAERS: 5US FAERS
101Sinus TachycardiaFAERS: 5US FAERS
102VertigoFAERS: 5US FAERS
103Burning sensationFAERS: 4US FAERS
104Drug effect delayedFAERS: 4US FAERS
105Extra dose administeredFAERS: 4US FAERS
106Inappropriate schedule of drug administrationFAERS: 4US FAERS
107Mental status changesFAERS: 4US FAERS
108NervousnessFAERS: 4US FAERS
109Paradoxical drug reactionFAERS: 4US FAERS
110Product formulation issueFAERS: 4US FAERS
111Unevaluable eventFAERS: 4US FAERS
112Accidental drug intake by childFAERS: 3US FAERS
113AphasiaFAERS: 3US FAERS
114BedriddenFAERS: 3US FAERS
115Blood creatine phosphokinase increasedFAERS: 3US FAERS
116Cerebrovascular accidentFAERS: 3US FAERS
117Chemical submissionFAERS: 3US FAERS
118ConstipationFAERS: 3US FAERS
119DehydrationFAERS: 3US FAERS
120Drug effect variableFAERS: 3US FAERS
121Drug exposure via breast milkFAERS: 3US FAERS
122Dry skinFAERS: 3US FAERS
123DyspepsiaFAERS: 3US FAERS
124DysphoniaFAERS: 3US FAERS
125Ear discomfortFAERS: 3US FAERS
126Feeling jitteryFAERS: 3US FAERS
127HomicideFAERS: 3US FAERS
128Lip swellingFAERS: 3US FAERS
129Mental impairmentFAERS: 3US FAERS
130Musculoskeletal PainFAERS: 3US FAERS
131MydriasisFAERS: 3US FAERS
132Myocardial InfarctionFAERS: 3US FAERS
133ParanoiaFAERS: 3US FAERS
134PneumoniaFAERS: 3US FAERS
135Posterior reversible encephalopathy syndromeFAERS: 3US FAERS
136Product counterfeitFAERS: 3US FAERS
137Product size issueFAERS: 3US FAERS
138Respiratory arrestFAERS: 3US FAERS
139Skin lacerationFAERS: 3US FAERS
140SluggishnessFAERS: 3US FAERS
141Throat irritationFAERS: 3US FAERS
142TinnitusFAERS: 3US FAERS
143Unresponsive to stimuliFAERS: 3US FAERS
144Urinary IncontinenceFAERS: 3US FAERS
145Weight decreasedFAERS: 3US FAERS
146nervous system disorderFAERS: 3US FAERS
147treatment failureFAERS: 3US FAERS
148Abdominal PainFAERS: 2US FAERS
149AcidosisFAERS: 2US FAERS
150Activities of daily living impairedFAERS: 2US FAERS
151AgoraphobiaFAERS: 2US FAERS
152Alanine aminotransferase decreasedFAERS: 2US FAERS
153ArthralgiaFAERS: 2US FAERS
154Aspartate aminotransferase decreasedFAERS: 2US FAERS
155Blood alcohol increasedFAERS: 2US FAERS
156Blood electrolytes abnormalFAERS: 2US FAERS
157Blood glucose increasedFAERS: 2US FAERS
158ChillsFAERS: 2US FAERS
159CholelithiasisFAERS: 2US FAERS
160DisabilityFAERS: 2US FAERS
161Dreamy stateFAERS: 2US FAERS
162Drug effect incompleteFAERS: 2US FAERS
163Drug level increasedFAERS: 2US FAERS
164Eye painFAERS: 2US FAERS
165Facial PainFAERS: 2US FAERS
166FlushingFAERS: 2US FAERS
167HyperacusisFAERS: 2US FAERS
168HyperphagiaFAERS: 2US FAERS
169HyperventilationFAERS: 2US FAERS
170HypokinesiaFAERS: 2US FAERS
171HyporeflexiaFAERS: 2US FAERS
172Near DrowningFAERS: 2US FAERS
173Nerve injuryFAERS: 2US FAERS
174NeuralgiaFAERS: 2US FAERS
175Night sweatsFAERS: 2US FAERS
176No adverse eventFAERS: 2US FAERS
177NystagmusFAERS: 2US FAERS
178Obsessive-Compulsive DisorderFAERS: 2US FAERS
179PallorFAERS: 2US FAERS
180Poor quality drug administeredFAERS: 2US FAERS
181Prescription drug used without a prescriptionFAERS: 2US FAERS
182Product availability issueFAERS: 2US FAERS
183Product measured potency issueFAERS: 2US FAERS
184Product packaging quantity issueFAERS: 2US FAERS
185Product physical issueFAERS: 2US FAERS
186Quality of life decreasedFAERS: 2US FAERS
187Reaction to excipientFAERS: 2US FAERS
188Renal painFAERS: 2US FAERS
189Respiratory FailureFAERS: 2US FAERS
190ScreamingFAERS: 2US FAERS
191ShockFAERS: 2US FAERS
192StarvationFAERS: 2US FAERS
193SwellingFAERS: 2US FAERS
194TalipesFAERS: 2US FAERS
195Therapeutic response delayedFAERS: 2US FAERS
196Urinary RetentionFAERS: 2US FAERS
197Urinary tract infectionFAERS: 2US FAERS
198Visual ImpairmentFAERS: 2US FAERS
199Visual disturbanceFAERS: 2US FAERS
200AbasiaFAERS: 1US FAERS
201Accidental exposure to productFAERS: 1US FAERS
202AkathisiaFAERS: 1US FAERS
203AngerFAERS: 1US FAERS
204AngioedemaFAERS: 1US FAERS
205Anorexia and bulimia syndromeFAERS: 1US FAERS
206ArthritisFAERS: 1US FAERS
207AsphyxiaFAERS: 1US FAERS
208AsthenopiaFAERS: 1US FAERS
209AuraFAERS: 1US FAERS
210Bipolar I disorderFAERS: 1US FAERS
211Bladder painFAERS: 1US FAERS
212Blood creatinine increasedFAERS: 1US FAERS
213Blood glucose decreasedFAERS: 1US FAERS
214Blood pressure fluctuationFAERS: 1US FAERS
215Blood triglycerides increasedFAERS: 1US FAERS
216Blood urine presentFAERS: 1US FAERS
217Borderline Personality DisorderFAERS: 1US FAERS
218Brain stem syndromeFAERS: 1US FAERS
219CellulitisFAERS: 1US FAERS
220CryingFAERS: 1US FAERS
221CyanosisFAERS: 1US FAERS
222Death of relativeFAERS: 1US FAERS
223Delayed sleep phaseFAERS: 1US FAERS
224DermatitisFAERS: 1US FAERS
225DiscomfortFAERS: 1US FAERS
226Dissociative disorderFAERS: 1US FAERS
227DrowningFAERS: 1US FAERS
228Drug dispensing errorFAERS: 1US FAERS
229Drug diversionFAERS: 1US FAERS
230Drug exposure during pregnancyFAERS: 1US FAERS
231Drug ineffective for unapproved indicationFAERS: 1US FAERS
232Drug level above therapeuticFAERS: 1US FAERS
233Drug screen negativeFAERS: 1US FAERS
234Drug screen positiveFAERS: 1US FAERS
235DysphemiaFAERS: 1US FAERS
236Dysthymic DisorderFAERS: 1US FAERS
237DystoniaFAERS: 1US FAERS
238Dystonic tremorFAERS: 1US FAERS
239Economic problemFAERS: 1US FAERS
240Eosinophilic PneumoniaFAERS: 1US FAERS
241EpistaxisFAERS: 1US FAERS
242EructationFAERS: 1US FAERS
243Erythema MultiformeFAERS: 1US FAERS
244Erythrodermic psoriasisFAERS: 1US FAERS
245Euphoric moodFAERS: 1US FAERS
246ExcoriationFAERS: 1US FAERS
247Exposure via breast milkFAERS: 1US FAERS
248Extremity necrosisFAERS: 1US FAERS
249Eye allergyFAERS: 1US FAERS
250FractureFAERS: 1US FAERS
251FrustrationFAERS: 1US FAERS
252GangreneFAERS: 1US FAERS
253Gastric DilatationFAERS: 1US FAERS
254Gastrointestinal sounds abnormalFAERS: 1US FAERS
255Genital burning sensationFAERS: 1US FAERS
256Global AmnesiaFAERS: 1US FAERS
257Hallucinations, mixedFAERS: 1US FAERS
258HepatitisFAERS: 1US FAERS
259HerniaFAERS: 1US FAERS
260HydrocephalusFAERS: 1US FAERS
261HyperkinesiaFAERS: 1US FAERS
262HypospadiasFAERS: 1US FAERS
263HypoxiaFAERS: 1US FAERS
264Impaired gastric emptyingFAERS: 1US FAERS
265Incorrect route of drug administrationFAERS: 1US FAERS
266InfarctionFAERS: 1US FAERS
267InflammationFAERS: 1US FAERS
268Intentional misuseFAERS: 1US FAERS
269Intentional misuse of drug delivery systemFAERS: 1US FAERS
270Irregular breathingFAERS: 1US FAERS
271Irritable Bowel SyndromeFAERS: 1US FAERS
272Lid sulcus deepenedFAERS: 1US FAERS
273Low birth weight babyFAERS: 1US FAERS
274LymphadenopathyFAERS: 1US FAERS
275Male sexual dysfunctionFAERS: 1US FAERS
276Manufacturing materials issueFAERS: 1US FAERS
277Medication residue presentFAERS: 1US FAERS
278Multiple drug overdoseFAERS: 1US FAERS
279Muscle tightnessFAERS: 1US FAERS
280Musculoskeletal discomfortFAERS: 1US FAERS
281Musculoskeletal stiffnessFAERS: 1US FAERS
282MyoclonusFAERS: 1US FAERS
283Myoglobin blood increasedFAERS: 1US FAERS
284NarcolepsyFAERS: 1US FAERS
285NasopharyngitisFAERS: 1US FAERS
286Neck PainFAERS: 1US FAERS
287Open woundFAERS: 1US FAERS
288Oropharyngeal blisteringFAERS: 1US FAERS
289Oropharyngeal discomfortFAERS: 1US FAERS
290Oropharyngeal painFAERS: 1US FAERS
291OsteoporosisFAERS: 1US FAERS
292ParaplegiaFAERS: 1US FAERS
293Personality ChangeFAERS: 1US FAERS
294Pharmaceutical product counterfeitFAERS: 1US FAERS
295Pharyngeal swellingFAERS: 1US FAERS
296PhotophobiaFAERS: 1US FAERS
297PneumothoraxFAERS: 1US FAERS
298PoisoningFAERS: 1US FAERS
299Pre-existing condition improvedFAERS: 1US FAERS
300Prescription form tamperingFAERS: 1US FAERS
301PresyncopeFAERS: 1US FAERS
302PriapismFAERS: 1US FAERS
303Product adhesion issueFAERS: 1US FAERS
304Product contamination physicalFAERS: 1US FAERS
305Product distribution issueFAERS: 1US FAERS
306Product package associated injuryFAERS: 1US FAERS
307Product quality control issueFAERS: 1US FAERS
308Pupillary light reflex tests abnormalFAERS: 1US FAERS
309Reaction to drug excipientsFAERS: 1US FAERS
310Rebound effectFAERS: 1US FAERS
311Refusal of treatment by relativeFAERS: 1US FAERS
312Retrograde amnesiaFAERS: 1US FAERS
313Rotator cuff syndromeFAERS: 1US FAERS
314SchizophreniaFAERS: 1US FAERS
315ShopliftingFAERS: 1US FAERS
316SinusitisFAERS: 1US FAERS
317Skin lesionFAERS: 1US FAERS
318SnoringFAERS: 1US FAERS
319Soft tissue inflammationFAERS: 1US FAERS
320StomatitisFAERS: 1US FAERS
321Sudden Cardiac DeathFAERS: 1US FAERS
322SyndactylyFAERS: 1US FAERS
323TheftFAERS: 1US FAERS
324Therapeutic product effect decreasedFAERS: 1US FAERS
325Therapeutic response changedFAERS: 1US FAERS
326Therapy non-responderFAERS: 1US FAERS
327Therapy responderFAERS: 1US FAERS
328Tooth ErosionFAERS: 1US FAERS
329ToothacheFAERS: 1US FAERS
330Ultrasound antenatal screenFAERS: 1US FAERS
331Vibratory sense increasedFAERS: 1US FAERS
332Victim of chemical submissionFAERS: 1US FAERS
333Victim of homicideFAERS: 1US FAERS
334WheezingFAERS: 1US FAERS
335Wrong drug administeredFAERS: 1US FAERS
336Wrong patient received medicationFAERS: 1US FAERS
337muscle injuryFAERS: 1US FAERS
338skin abrasionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.